In re Skelaxin (Metaxalone) Antitrust Litigation
The court denied both the end payors’ and indirect purchasers’ motions for class certification in this pharmaceutical reverse payment antitrust case.
Cornerstone Research Coauthors Antitrust Amicus Brief for Supreme Court
Filing Details Economic Evidence Against Using a Presumption of Illegality for Reverse Payment Settlements of Pharmaceutical Patent Infringement Suits
Boston Scientific Corp. et al. v. Cordis Corp.
Counsel for Boston Scientific retained Mary Woodford, a senior advisor at Cornerstone Research, to provide damages analysis and testimony in the May 2011 damages trial.
In re Northfield Laboratories, Inc., Securities Litigation
Counsel for the defendants retained Cornerstone Research and Professor Paul Gompers of Harvard Business School to analyze economic issues pertinent to class certification in this matter.
In re Boston Scientific Corporation Securities Litigation
This Rule 10b-5 case involved allegations that the company withheld material information about alleged faults with a medical device that it eventually recalled.
Medical Devices
The exclusive licensee and the owners of a portfolio of patents related to certain medical devices alleged one of the licensee’s leading competitors had infringed one of the patents in…
Siemens Medical Solutions USA, Inc. v. Saint-Gobain Ceramics & Plastics, Inc.
Siemens’ counsel retained Mary Woodford, a vice president of Cornerstone Research, to assess the damages that Siemens had suffered due to the patent infringement.
Incremental Dental Positioning Adjustment Appliances
Align Technology sued OrthoClear (a foreign manufacturer) for patent infringement under Section 337 of the International Trade Commission.
Biotechnology Joint Development Agreement
Cornerstone Research worked with Professor Iain Cockburn of Boston University in a breach-of-contract dispute between two biotechnology companies.
Average Wholesale Price Litigation
Cornerstone Research has worked with counsel for several pharmaceutical companies on state False Claims Act cases alleging that these companies caused state Medicaid agencies to overpay for prescription drugs by…
How can we help you?
If you are looking for additional case experience examples, contact us.